sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Feb-2015 18:07
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 958.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 27-Feb-2015
Liberia-US clinical research partnership opens trial to test Ebola treatments
In partnership with the Liberian government, the National Institute of Allergy and Infectious Diseases today launched a clinical trial to obtain safety and efficacy data on the investigational drug ZMapp as a treatment for Ebola virus disease. The study, which will be conducted in Liberia and the United States, is a randomized controlled trial enrolling adults and children with known Ebola virus infection.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 26-Feb-2015
Cell
Researchers identify how humans can develop immunity to deadly Marburg virus
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University and The Scripps Research Institute have identified mechanisms involved in antibody response to the deadly Marburg virus by studying the blood of a Marburg survivor. Using blood samples from a Marburg survivor, the researchers were able to determine how a person's immune system can fight against the virus.
Defense Threat Reduction Agency, National Institutes of Health

Contact: Donna Ramirez
donna.ramirez@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston

Public Release: 26-Feb-2015
Cochrane Library
New evidence helps health workers in the fight against Ebola
One year after the first Ebola cases started to surface in Guinea, the latest findings from a Cochrane review show new ways of hydrating patients in critical care environments across the world.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley

Public Release: 26-Feb-2015
Bioethics commission: Ebola teaches us public health preparedness requires ethics preparedness
Today the Presidential Commission for the Study of Bioethical Issues reported that the federal government has both a prudential and a moral responsibility to actively participate in coordinated global responses to public health emergencies wherever they arise.

Contact: Hillary Wicai Viers
Hillary.Viers@bioethics.com
202-233-3963
Burness Communications

Public Release: 26-Feb-2015
Cell
TSRI team shows how rare antibody targets Ebola and Marburg virus
Scientists at The Scripps Research Institute have captured the first images showing how immune molecules bind to a site on the surface of Marburg virus, pointing a way to target the virus's weak spots with future treatments. The research team is also the first to describe an antibody that binds to both Marburg and Ebola viruses, paving the way for new antibody treatments to fight an entire family of viruses.
National Institutes of Health, Defense Threat Reduction Agency, MEXT KAKENHI, MEXT Platform for Drug Discovery Informatics and Structural Life Science, Japanese Society for the Promotion of Science, The Uehara Memorial Foundation, and others

Contact: Madeline McCurry-Schmidt
madms@scripps.edu
858-784-9254
Scripps Research Institute

Public Release: 26-Feb-2015
Cell
Human antibodies target Marburg, Ebola viruses; 1 step closer to vaccine
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.
DOD/Defense Threat Reduction Agency, National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 25-Feb-2015
Proceedings of the National Academy of Sciences
Malaria plays hide-and-seek with immune system by using long noncoding RNA to switch genes
Up to a million people are killed each year by the Plasmodium falciparum parasite, which causes malaria. Hebrew University of Jerusalem researchers have now revealed the genetic trickery the parasite deploys to escape attack by the immune system. They also developed a novel way to interfere with the parasite's deadly game of genetic hide-and-seek, and to manipulate which genes it displays to the immune system. This breakthrough could potentially lead to new therapies and vaccines.
Israel Academy of Science and Humanities, European Research Council, Abisch-Frenkel Foundation

Contact: Dov Smith
dovs@savion.huji.ac.il
972-258-82844
The Hebrew University of Jerusalem

Public Release: 24-Feb-2015
DRI launches global initiative to provide women in developing countries with clean water
Imagine a day in which your access to clean, drinkable water ceased and you could not shower or bathe properly and you had no one to help you. For more than 783 million people around the world, that day was today. A new initiative led by Nevada's Desert Research Institute is aiming to dramatically reduce those numbers, focusing specifically on women in developing countries.

Contact: Justin Broglio
justin.broglio@dri.edu
775-673-7610
Desert Research Institute

Public Release: 24-Feb-2015
eLife
Airport screening for viruses misses half of infected travelers but can be improved
Airport screening for diseases often misses at least half of infected travelers, but can be improved, scientists reported Feb. 19 in eLife, a highly regarded open-access online science journal. The life scientists used a mathematical model to analyze screening for six viruses: SARS coronavirus, Ebola virus, Middle East respiratory syndrome coronavirus, Marburg virus, Influenza H1N1 and Influenza H7N9.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Public Release: 24-Feb-2015
Bioorganic and Medicinal Chemistry Letters
UGA researchers discover potential treatment for drug-resistant tuberculosis
Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multi-drug resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. While standard anti-tuberculosis drugs can cure most people of Mycobacterium tuberculosis infection, improper use of antibiotics has led to new strains of the bacterium resistant to the two most powerful medications, isoniazid and rifampicin.
National Institutes of Health

Contact: Vasu Nair
vnair@uga.edu
706-542-6293
University of Georgia

Public Release: 24-Feb-2015
New US patent for LGTmedical's Kenek Core audio waveform technology
LionsGate Technologies Inc., a privately held medical device company, announced today that the US Patent and Trademark Office has issued a patent for its pulse oximetry technology based on the Kenek Core proprietary audio waveform platform. This innovation transforms smartphones and tablets into clinically accurate medical devices by connecting simple, inexpensive sensors to the mobile device's audio port.

Contact: Pamela Clarke
pamela.clarke@lgtmedical.com
604-983-8627
LionsGate Technologies (LGTmedical)

Public Release: 24-Feb-2015
Polio vaccination with microneedle patches receives funding
The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization.
Bill & Melinda Gates Foundation

Contact: John Toon
jtoon@gatech.edu
404-894-6986
Georgia Institute of Technology

Public Release: 24-Feb-2015
Evidence supports use of 'retainer' contact lenses for nearsightedness in children, reports Optometry and Vision Science
A technique called orthokeratology ('Ortho-K') -- using custom-made contact lenses to shape the growing eye -- has a significant effect in slowing the progression of myopia (nearsightedness) in children, according to a research review in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 24-Feb-2015
Lab on a Chip
Quick test for Ebola
Using a simple paper strip similar to a pregnancy test, MIT researchers have found a way to rapidly diagnose Ebola, as well as other viral hemorrhagic fevers such as yellow fever and dengue fever.
NIH/National Institute of Allergy and Infectious Disease

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 23-Feb-2015
UTHealth's Cesar A. Arias elected to American Society for Clinical Investigation
Cesar A. Arias, M.D., Ph.D., associate professor in the Division of Infectious Diseases at The University of Texas Health Science Center at Houston Medical School, has been elected to the American Society for Clinical Investigation. It is an honor society comprised of more than 3,000 physician scientists.

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 23-Feb-2015
Stem Cells Translational Medicine
Wisdom teeth stem cells can transform into cells that could treat corneal scarring
Stem cells from the dental pulp of wisdom teeth can be coaxed to become cells of the eye's cornea and could one day be used to repair corneal scarring due to infection or injury, according to researchers at the University of Pittsburgh School of Medicine. The findings, published online today in STEM CELLS Translational Medicine, indicate they also could become a new source of corneal transplant tissue made from the patient's own cells.
National Institutes of Health, Research to Prevent Blindness, Eye and Ear Foundation of Pittsburgh

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences

Public Release: 23-Feb-2015
American Journal of Tropical Medicine and Hygiene
New study: Agriculture expansion in Tanzania may greatly increase human plague risk
The push to boost food production in East Africa that is accelerating the conversion of natural lands into croplands may be significantly increasing the risk of plague according to a new study published online today in the American Journal of Tropical Medicine and Hygiene.

Contact: Preeti Singh
psingh@burness.com
301-280-5722
Burness Communications

Public Release: 20-Feb-2015
LSU researcher receives $1.8 million NIH grant to study proteins in rickettsial species
Juan J. Martinez, Ph.D., associate professor in the Department of Pathobiological Sciences at the LSU School of Veterinary Medicine, has been awarded a five-year grant from the National Institutes of Health, National Institute of Allergy and Infectious Disease to further understand the contribution of a family of outer-membrane proteins termed surface cell antigens, expressed by pathogenic rickettsial species to the initiation and progression of disease in animals and humans.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Disease

Contact: Ginger Guttner
ginger@lsu.edu
225-578-9922
Louisiana State University

Public Release: 19-Feb-2015
Zoonoses and Public Health
Study exposes shocking lack of rabies reporting in countries where risk is greatest
The first global survey of rabies reporting systems, published this week, has uncovered a shocking lack of preparedness against this deadly disease across Africa and Asia. Accurate reporting of rabies cases to authorities is a critical first step in controlling rabies and preventing further outbreaks, yet the study found that over 2.5 billion people live in countries without effective rabies reporting.
UBS Optimus Foundation

Contact: Louise Taylor
media@rabiesalliance.org
Global Alliance for Rabies Control

Public Release: 19-Feb-2015
Lancet Infectious Diseases
Study in Myanmar confirms artemisinin-resistant malaria close to border with India
Resistance to the antimalarial drug artemisinin is established in Myanmar and has reached within 25km of the Indian border, a study published today in Lancet Infectious Diseases reports. Artemisinin resistance threatens to follow the same historical trajectory from Southeast Asia to the Indian subcontinent as seen in the past with other antimalarial medicines.

Contact: Clare Ryan
c.ryan@wellcome.ac.uk
44-020-761-17262
Wellcome Trust

Public Release: 18-Feb-2015
Journal of Clinical Investigation
Possible strategy identified to combat major parasitic tropical disease
Research led by St. Jude Children's Research Hospital scientists has identified a potential target in the quest to develop a more effective treatment for leishmaniasis, a parasitic tropical disease that kills thousands and sickens more than 1 million people worldwide each year. The findings were published online in the Journal of Clinical Investigation.
National Institutes of Health, European Research Council, Fund for Scientific Research-Flanders, American Lebanese Syrian Associated Charities

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 18-Feb-2015
Disaster Medicine and Public Health Preparedness
Ebola and the International Health Regulations Treaty
The West Africa Ebola outbreak has shone a spotlight on lapses in the 2007 International Health Regulations Treaty, which was intended to improve the capacity of all countries to detect, assess, notify, and respond to public health threats of international concern.

Contact: Alice O'Donnell
dmphpjournal@gmail.com
240-833-4429
Society for Disaster Medicine and Public Health

Public Release: 17-Feb-2015
Journal of Pharmacology and Experimental Therapeutics
Nicotine metabolite amplifies action of the primary chemical messenger for learning and memory
Nicotine's primary metabolite supports learning and memory by amplifying the action of a primary chemical messenger involved in both, researchers report.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 15-Feb-2015
2015 AAAS Annual Meeting
An Italian cemetery may provide clues on cholera's evolution
A team of archaeologists and other researchers hope that an ancient graveyard in Italy can yield clues about the deadly bacterium that causes cholera.

Contact: Jeff Grabmeier
grabmeier.1@osu.edu
614-292-8457
Ohio State University

Public Release: 13-Feb-2015
2015 AAAS Annual Meeting
Lighting up a new path for novel synthetic polio vaccine
Scientists from the UK and USA are using technology that helped in the design of a new synthetic vaccine to combat the foot and mouth disease virus to target the virus that causes polio. The vaccine for FMDV does not contain the viral genome but instead 'mimics' the structure of the live virus. This project is being funded by a £438,000 grant from the World Health Organisation and Bill & Melinda Gates Foundation.
World Health OrganisationBill and Melinda Gates Foundation

Contact: Silvana Westbury
silvana.westbury@diamond.ac.uk
44-079-205-94660
Diamond Light Source

Showing releases 1-25 out of 958.

1 | 2 | 3 | 4 | 5 > >>